Trial Profile
Phase II trial to evaluate the maintenance of ovulation inhibition with LF111 (drospirenone 4.0 mg 24/4 regimen) after scheduled 24-hour delays in pill intake.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jul 2017
Price :
$35
*
At a glance
- Drugs Drospirenone (Primary) ; Oral contraceptives
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Leon Farma
- 16 Dec 2015 Results published in the Contraception
- 25 Jun 2013 New trial record